E717-0477 Screening compound: N-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2-{4-oxo-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide

E717-0477 Screening compound: N-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2-{4-oxo-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide
E717-0477 Screening compound: N-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2-{4-oxo-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E717-0477
N-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2-{4-oxo-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E717-0477

Molecular Formula

C25H27FN6O2 (C25 H27 FN6 O2)

Compound Name

N-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2-{4-oxo-3H,4H,5H-pyridazino[4,5-b]indol-3-yl}acetamide

IUPAC name

N-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2-{4-oxo-3H4H5H-pyridazino[45-b]indol-3-yl}acetamide

SMILES

O=C(CN(C1=O)N=Cc2c1[nH]c1c2cccc1)NCCCN(CC1)CCN1c(cc1)ccc1F

InChI

InChI=1S/C25H27FN6O2/c26-18-6-8-19(9-7-18)31-14-12-30(13-15-31)11-3-10-27-23(33)17-32-25(34)24-21(16-28-32)20-4-1-2-5-22(20)29-24/h1-2,4-9,16,29H,3,10-15,17H2,(H,27,33)

InChI Key

WADJAPYNFZHBSG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14912262

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

462.53

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.753

Distribution Coefficient, logD

1.166

Water Solubility, LogSw

-2.55

Polar Surface Area

69.996

Acid Dissociation Constant (pKa)

14.06

Base Dissociation Constant (pKb)

7.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

E717-0477 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E717-0477 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E717-0477?
Check Price and Availability of E717-0477, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E717-0477 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E717-0477
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E717-0477
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E717-0477 available by request